The Use of Both Internal Thoracic Arteries for Coronary Revascularization Increases the Estimate of Post-Operative Lower Limb Ischemia in Patients with Peripheral Artery Disease - DocWire News
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Comments
Post a Comment